Jin-Hyuk Choi

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

Sung Hoon Noh, Sook Ryun Park, Han‐Kwang Yang et al. · The Lancet Oncology · 2014 · 1K citations · Full text

Gastrointestinal Oncology, Medicine, Randomised Phase 3 +7

Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib

W.J. Lee, J.L. Lee, S.E. Chang et al. · British Journal of Dermatology · 2009 · 233 citations

Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13–01)

Yun‐Gyoo Lee, Eun Joo Kang, Bhumsuk Keam et al. · BMC Cancer · 2020 · 68 citations · Full text

Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer

Dong‐Wan Kim, Hoon-Gu Kim, Joo-Hang Kim et al. · Cancer Research and Treatment · 2018 · 45 citations · Full text

Patterns of Neutropenia and Risk Factors for Febrile Neutropenia of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP

Yong Won Choi, Seong Hyun Jeong, Mi Sun Ahn et al. · Journal of Korean Medical Science · 2014 · 32 citations · Full text

Immunodeficiencies, Immunology, Pathology +16